Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals submits press release

02 Dec 2019 Evaluate

Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Tentative Approval for Diclofenac Sodium Topical Solution USP, 2% w/w. The company has submitted its press release. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1763.00
Dr. Reddys Labs. 1310.85
Cipla 1344.65
Lupin 1951.60
Zydus Lifesciences 1169.40
View more..